The Role of MicroRNAs in Diabetic Nephropathy

被引：59
|
作者：
Wu, Hao [1 ,2 ,3 ]
Kong, Lili [1 ,3 ]
Zhou, Shanshan [3 ,4 ]
Cui, Wenpeng [1 ]
Xu, Feng [1 ]
Luo, Manyu [1 ,3 ]
Li, Xiangqi [5 ]
Tan, Yi [2 ,3 ]
Miao, Lining [1 ]
机构：
[1] Jilin Univ, Hosp 2, Dept Nephrol, Changchun 130041, Peoples R China
[2] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou 325035, Peoples R China
[3] Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pediat, Louisville, KY 40202 USA
[4] Jilin Univ, Cardiovasc Ctr, Hosp 1, Changchun 130021, Peoples R China
[5] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China
来源：
JOURNAL OF DIABETES RESEARCH | 2014年 / 2014卷
基金：
美国国家科学基金会;
关键词：
NF-KAPPA-B; INDUCED COLLAGEN EXPRESSION; GROWTH-FACTOR; RENAL FIBROSIS; HEPATOCELLULAR-CARCINOMA; UP-REGULATION; FIBRONECTIN EXPRESSION; MESANGIAL HYPERTROPHY; THERAPEUTIC TARGET; PROMOTES APOPTOSIS;
D O I：
10.1155/2014/920134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Diabetic nephropathy (DN), as one of the chronic complications of diabetes, is the major cause of end-stage renal disease. However, the pathogenesis of this disease is not fully understood. In recent years, research on microRNAs (miRNAs) has become a hotspot because of their critical role in regulating posttranscriptional levels of protein-coding genes that may serve as key pathogenic factors in diseases. Several miRNAs were found to participate in the pathogenesis of DN, while others showed renal protective effects. Therefore, targeting miRNAs that are involved in DN may have a good prospect in the treatment of the disease. The aim of this review is to summarize DN-related miRNAs and provide potential targets for diagnostic strategies and therapeutic intervention.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment
    Yarahmadi, Amir
    Shahrokhi, Seyedeh Zahra
    Mostafavi-Pour, Zohreh
    Azarpira, Negar
    BIOCHEMICAL PHARMACOLOGY, 2021, 189
  • [22] The role of cellular crosstalk in the progression of diabetic nephropathy
    Zhang, Keying
    Fu, Zhangning
    Zhang, Yifan
    Chen, Xiangmei
    Cai, Guangyan
    Hong, Quan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [23] Research progress in signalling pathway in diabetic nephropathy
    Ni, Wei-Jian
    Tang, Li-Qin
    Wei, Wei
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (03) : 221 - 233
  • [24] The Endothelium in Diabetic Nephropathy
    Gilbert, Richard E.
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (05)
  • [25] MicroRNAs in IgA nephropathy
    Yao, Xingchen
    Zhai, Yaling
    An, Huanping
    Gao, Jingge
    Chen, Yazhuo
    Zhang, Wenhui
    Zhao, Zhanzheng
    RENAL FAILURE, 2021, 43 (01) : 1298 - 1310
  • [26] Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy
    Widiasta, Ahmedz
    Sribudiani, Yunia
    Nugrahapraja, Husna
    Hilmanto, Dany
    Sekarwana, Nanan
    Rachmadi, Dedi
    NON-CODING RNA RESEARCH, 2020, 5 (04): : 153 - 166
  • [27] microRNAs in Diabetic Kidney Disease
    Chung, Arthur C. K.
    MICRORNA: MEDICAL EVIDENCE: FROM MOLECULAR BIOLOGY TO CLINICAL PRACTICE, 2015, 888 : 253 - 269
  • [28] MicroRNAs in Diabetic Kidney Disease
    Li, Rong
    Chung, Arthur C. K.
    Yu, Xueqing
    Lan, Hui Y.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [29] MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes
    Abdelghaffar, Shereen
    Shora, Hassan
    Abdelatty, Sahar
    Elmougy, Fatma
    El Sayed, Reham
    Abdelrahman, Heba
    Soliman, Hend
    Algebaly, HebatAllah
    Ahmed, Sakinatalfouad
    Alfy, Peter
    Elshiwy, Yasmine
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 2485 - 2494
  • [30] Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review
    Kumari, Anita
    Sodum, Nalini
    Ravichandiran, Velayutham
    Kumar, Nitesh
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (08) : 811 - 831
12345